Tinna Rubber and Infrastructure Limited (TRIL) announced record H1FY27 profitability with a 50% YoY EBITDA growth. The company reported consolidated revenue of ₹313 crore, up 25% YoY. The EBITDA surged to ₹63 crore, a 50% increase compared to the previous year. The PAT also rose by 60% to ₹38 crore. This growth was driven by strong performance across all segments, including a 38% YoY growth in Infrastructure. The balance sheet strength improved with debt declining by 9% to ₹111 crore. The company’s credit ratings were upgraded by CARE Ratings, and its MRP capacity expansion is on track to be commissioned by Q3 FY27. Notably, renewable energy accounted for 40% of total power consumption, supporting cost savings of ₹2.37 crore.

Financial Highlights

TRIL achieved record H1 profitability on both standalone and consolidated bases. Standalone EBITDA exceeded ₹61 crore, and PAT surpassed ₹36 crore, with strong EBITDA and PAT margins of above 20% and 12%, respectively. Consolidated Q2FY27 revenue, EBITDA, and PAT grew 31%, 37%, and 45% YoY, respectively, with margins above 18% and 10%.

Operational & Strategic Highlights

The company’s ongoing MRP capacity expansion is progressing as planned and will be commissioned by Q3 FY27, increasing MRP capacity to 20,000 MTPA. Polymer Composites & Masterbatch (PCMB) revenue tripled to ₹27 crore in H1FY27. The company completed Rs. 45 crore of capex in H1 FY27 against the planned Rs. 100 crore investment over FY27-FY28. Plans to invest up to Rs. 250 crore over the next three years to develop a 40-acre integrated recycling facility in Andhra Pradesh are also underway.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Tinna Rubber and Infrastructure Limited

Tinna Rubber and Infrastructure Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.

Tinna moves sideways over three months, with neither buyers nor sellers taking control. The PEG of 0.77 signals undervaluation relative to growth. It is a potential re-rating candidate. Revenue grows at 22.8% and profits at 34.3% CAGR. Both numbers are exceptional. The stock holds at 49% of its 52-week range with RSI at 43. In other words, neither side has a clear edge right now. Both the business and the stock move in the right direction. Revenue grows at 22.8%, profits at 34.3%, and the PEG sits at 0.77 — below its growth rate. That combination is rare. Check Fundamentals of Tinna Rubber and Infrastructure Limited.

Bansal Wire Industries Limited (NSE: BANSALWIRE) has announced its financial results for the second quarter and half year ended September 30, 2026. The company’s revenue for the quarter stood at ₹1,308.1 Crore, marking a 23.9% year-on-year increase. This impressive performance is driven by a combination of a richer product mix and a more efficient Dadri plant.

Record-Breaking EBITDA

The company’s EBITDA for the quarter stood at ₹105.0 Crore, marking a 28.7% year-on-year increase and the highest-ever quarterly EBITDA. This achievement is attributed to the higher sales volume and improved operational efficiency.

Sales Volume Milestones

Bansal Wire Industries Limited achieved its highest-ever quarterly sales volume of 1,28,867 MT in Q2 FY27, up 12.4% year-on-year. The half-yearly sales volume also reached 2,40,812 MT, up 10.1% year-on-year. This growth is expected to continue as the company expands its capacity and focuses on higher-margin products.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Bansal Wire Industries Limited

Bansal Wire Industries Limited belongs to the Basic Materials › Steel sector. Here’s a quick read on where the business and the stock stand today.

Bansal drops 80.3% over three months and trades near its 52-week lows. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. The business compounds revenue at 19.8% and profits at 39.0% CAGR. That is strong double-digit growth on both counts. RSI stands at 8, well into oversold territory. Yet sellers still dominated on 18 of recent sessions versus 11 for buyers, so the pressure has not fully lifted. The business compounds at 19.8% revenue and 39.0% profit CAGR, with D/E of 0.48. Yet the stock drops 80.3% in three months. The business does not deteriorate — the stock does. That gap is what long-term investors look for. Check Fundamentals of Bansal Wire Industries Limited.

Sandur Manganese & Iron Ores Limited (SMIORE or ‘the Company’), the flagship company of the Royal Sandur Group, has taken a decisive step towards its foray into the Medical Devices and Consumables business. Royal Sandur MedTech Private Limited, a wholly owned subsidiary of the Company, has taken land on a long-term lease at the Andhra Pradesh MedTech Zone (‘AMTZ’), Visakhapatnam, India’s premier medical technology park with common manufacturing facilities and scientific facilities.

Strategic Move for Diversification

The lease deed was executed on 19 October 2026 between Royal Sandur MedTech Private Limited and Andhra Pradesh MedTech Zone Limited, the Government of Andhra Pradesh undertaking that owns and operates AMTZ, for setting up a manufacturing unit at AMTZ. This marks a concrete move by SMIORE towards new frontiers, as part of its comprehensive diversification strategy.

Key Terms of the Land Lease

Royal Sandur MedTech Private Limited has also taken office space at World Trade Center AMTZ to support project development. Key terms of the land lease are as follows: Developed land measuring 6.2 acres (about 25,090 square metres), with road, power, water and effluent infrastructure provided by AMTZ. Lease tenure of 33 years from the date of execution, with an exclusive right to convert the leasehold rights into freehold ownership after 10 years from the date of commissioning of business.

Future Plans

Further details on the capital expenditure plans and project timelines will be announced in due course. Commenting on the development, Bahirji A. Ghorpade, Managing Director, SMIORE, said: “Our diversification strategy is about building new engines of growth alongside our core mining and metals businesses. Medical Devices and Consumables sector offers considerable opportunities for domestic manufacturing to grow, and the Andhra Pradesh MedTech Zone, with its common manufacturing and scientific facilities, gives a new entrant the right platform to build capabilities in a focused and capital-efficient manner. Securing this land is the first concrete step in this journey, and we intend to pursue it with the same discipline that has defined our enterprise over seven decades.”

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Sandur Manganese & Iron Ores Limited

Sandur Manganese & Iron Ores Limited belongs to the Basic Materials › Steel sector. Here’s a quick read on where the business and the stock stand today.

Sandur falls 10.8% over three months and has not found a floor yet. The PEG of 0.35 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. Revenue grows at 33.5% and profits at 34.3% CAGR. Both numbers are exceptional. The stock sits at 4% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 33.5% and profits at 34.3% CAGR, with D/E of 0.00. Meanwhile, the stock dips 10.8% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Sandur Manganese & Iron Ores Limited.